ZAGENO has raised $121.0M in total across 4 funding rounds.
ZAGENO's investors include Acton Capital Partners, Better Tomorrow Ventures, Capnamic Ventures, Cavalry Ventures, Earlybird Venture Capital, Founder Collective, General Catalyst, Highland Capital Partners, Iris Capital, Polaris Partners, Stellar Capital, The Hit Forge.
ZAGENO is an AI-powered e-commerce marketplace and procurement software platform tailored for the life sciences industry, connecting researchers, lab managers, and procurement teams with over 40 million products from more than 5,300 global suppliers.[1][4][5] It serves biotech, pharma, academic institutions, and government research facilities by automating lab supply procurement, enabling consolidated purchasing, real-time spend tracking, and cost reductions of 20-40% through price comparison, custom approvals, and analytics.[1][2] The platform solves fragmented ordering—where scientists spend 4-8 hours weekly on supply tracking—by streamlining requisition to invoice processing, offloading supplier management, and providing AI-driven search with unbiased 'Scientific Score' ratings.[1][3]
Growth momentum is strong, evidenced by Frost & Sullivan's 2025 Global Company of the Year award for life sciences e-commerce leadership, seamless integrations with ERP systems like SAP Ariba and NetSuite, and expansion to handle end-to-end fulfillment via partnerships like Logicbroker since 2022.[3][9]
ZAGENO emerged from founders' observations of inefficiencies in pharmaceutical and biotech lab supplies, where scientists wasted 4-8 hours weekly on ordering and tracking, while lab managers juggled hundreds of suppliers.[3] Led by CEO Florian Wegener and CPO David Pumberger, the company was founded to create a dual-sided B2B marketplace that aggregates suppliers and simplifies procurement beyond basic catalogs, including post-order tracking, billing, and integrations.[3][4] Early traction built on this vision of digital aggregation in life sciences, evolving into the industry's largest marketplace with rapid supplier onboarding (within hours) and AI enhancements, humanizing the process to prioritize scientists' "eureka moments" over administrative burdens.[1][4]
ZAGENO rides the wave of AI and automation in biotech procurement, aligning with trends like generative AI for drug discovery, FAIR data principles for interoperable R&D workflows, and RegTech for compliance.[7] Timing is ideal amid rising drug development pressures, where siloed suppliers and manual processes delay milestones; ZAGENO accelerates this by predicting delays, automating logistics, and turning procurement into a data source for R&D-finance alignment.[1][7] Market forces favoring it include explosive life sciences growth, ERP integration demands, and the shift to consolidated marketplaces, positioning ZAGENO to influence the ecosystem as the "single source" for supplies, reducing administrative drag and enabling faster innovation across biotech pipelines.[4][6][9]
ZAGENO is poised to dominate life sciences e-commerce through deeper AI enhancements, expanded supplier networks, and regulatory automation integrations, capitalizing on biotech's AI-driven acceleration.[7][9] Trends like FAIR-compliant data flows and predictive supply chain tech will shape its path, potentially evolving it into a full R&D operations hub. As the 2025 award winner signals, its influence will grow by further slashing procurement friction, freeing scientists for breakthroughs and solidifying its role in fueling scientific discovery.[9] This builds on its core mission: turning lab supply chaos into efficiency for those pivotal eureka moments.[4]
ZAGENO has raised $121.0M across 4 funding rounds. Most recently, it raised $33.0M Venture Round in May 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2023 | $33.0M Venture Round | Acton Capital Partners, Better Tomorrow Ventures, Capnamic Ventures, Cavalry Ventures, Earlybird Venture Capital, Founder Collective, General Catalyst, Highland Capital Partners, Iris Capital, Polaris Partners, Stellar Capital, The Hit Forge, Gautam Gupta, Greg Brockman, Jeff Arnold, Oliver Roskopf, Peter Fishman | |
| Nov 1, 2021 | $60.0M Series C | Acton Capital Partners, Capnamic Ventures, Cavalry Ventures, Earlybird Venture Capital, Iris Capital, Oliver Roskopf | |
| Apr 1, 2019 | $20.0M Series B | Acton Capital Partners, Capnamic Ventures, Cavalry Ventures, Earlybird Venture Capital, Iris Capital, Oliver Roskopf | |
| Oct 1, 2017 | $8.0M Series A | Acton Capital Partners, Capnamic Ventures, Cavalry Ventures, Earlybird Venture Capital, Iris Capital, Oliver Roskopf |
